To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Safeguarding Women from Chemical Abortion Act. S. 4066. 119th
Cong., 2nd
sess., Introduced in Senate March 11, 2026. https://www.govinfo.gov/app/details/BILLS-119s4066is.
APA
Congress, Senate (2026, March 11). Safeguarding Women from Chemical Abortion Act (S. 4066 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s4066is.
MLA
United States, Congress, Senate. Safeguarding Women from Chemical Abortion Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s4066is. 119th Congress, S. 4066, Introduced in Senate 11 Mar. 2026.
Bluebook
S.4066 - 119th Congress (2025-2026): Safeguarding Women from Chemical Abortion Act, S.4066, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119s4066is.
